undamentalytics Newsletter
Sign in

Agilent Technologies income statement

In fiscal 2025, Agilent Technologies reported revenue of $6.95bn, up 6.7% on the year before, operating income of $1.48bn (a 21.3% margin) and net income of $1.30bn, or $4.57 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Oct 20092010Oct 20102011Oct 20112012Oct 20122013Oct 20132014Oct 20142015Oct 20152016Oct 20162017Oct 20172018Oct 20182019Oct 20192020Oct 20202021Oct 20212022Oct 20222023Oct 20232024Oct 20242025Oct 2025LTMJul 2026
Revenue4,4815,4446,6156,8583,8944,0484,0384,2024,4724,9145,1635,3396,3196,8486,8336,5106,9487,372
Cost of revenue2,1892,5143,0863,2541,9872,0721,9972,0052,0632,2342,3582,5022,9123,1263,3682,9753,3053,404
Gross profit2,2922,9303,5293,6041,9071,9762,0412,1972,4092,6802,8052,8373,4073,7223,4653,5353,6433,968
Research and development642612649668337358330329341387404495441467481479455485
Selling, general and administrative1,6031,7521,8091,8171,1841,1991,1891,2531,2511,3891,4601,4961,6191,6371,6341,5681,7091,844
Operating income475661,0711,1193864195226158079049418461,3471,6181,3501,4881,4791,639
Interest expense88968610110711066727975747881849596112106
Income before tax79381,3101,3847327637678599749469198421,3601,5041,3391,5211,4351,658
Income tax38820−11068−34282119630−15212315025099232132218
Net income−316841,0121,1537345494014626843161,0717191,2101,2541,2401,2891,3031,440
Diluted EPS−$0.09$1.94$2.85$3.27$2.13$1.62$1.20$1.40$2.10$0.97$3.37$2.30$3.94$4.18$4.19$4.43$4.57$5.08
Diluted shares (average)346m353m355m353m345m338m335m329m326m325m318m312m307m300m296m291m285m283m
EBITDA2097681,3241,4207588037758611,0191,1141,1791,1541,6681,9351,6211,7451,7671,910

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: A vs AVTRA vs ICLRA vs WAT

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Agilent Technologies's SEC filings (10-K and 10-Q), retrieved October 20, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Agilent Technologies.